Fri, Sep 07, 2012
Closing the Research Therapeutic Loop
“From bench to bedside” is an often-heard phrase bandied about in various healthcare disciplines, from drug discovery to translational research and personalized medicine. The underlying meaning, across disciplines, is the same: translating as quickly and safely as possible bench research to point-of
... more »
Thu, Aug 09, 2012
Battles Over FDA Use Code Challenge Branded Drug Exclusivity
Successful marketing of pharmaceutical drugs can be put at risk if the approval to market a new drug with the Food and Drug Administration (FDA) is not carefully conducted in parallel with the issuance of patents from the U.S. Patent and Trademark Office (USPTO).
Two recent Federal Circuit decision
... more »
Thu, Aug 02, 2012
Curing Cancer in the Cell Culture Flask
When President Richard Nixon signed into law the National Cancer Act of 1971, declaring the “War on Cancer,” he began what is now a 40-plus year-long effort to eliminate cancer as a major cause of death. At the time, curing cancer probably seemed a realistic goal for a nation that had just put a man
... more »
Fri, Jul 27, 2012
How to Produce Conclusive, Reproducible RT-qPCR Data Every Time
Reverse-transcription quantitative polymerase chain reaction (RT-qPCR) is everywhere. Its ubiquity, however, does not mean its practitioners produce consistent and reproducible results that reflect the underlying biology. The exquisite sensitivity of RT-qPCR demands rigorous experimental design; the
... more »
Mon, Jul 23, 2012
Biotech Booming in Birmingham
Rich reserves of iron and coal once made Birmingham a major producer of iron and steel. In fact, the city’s nickname was “The Pittsburgh of the South.” Like Pittsburgh, the steel industry and local economy sharply declined, and now clean technology companies are boosting Birmingham’s economy. Many o
... more »